MIFEPRISTONE oral

Select language:
On this page

     

    Prescription under medical supervision

     

    Therapeutic action

    • Antiprogestogen

    Indications

    • Termination of intra-uterine pregnancy up to 22 weeks after the last menstrual period, in combination with misoprostol

    Forms and strengths

    • 200 mg tablet

    Dosage and duration

    • 200 mg single dose, followed by the administration of misoprostol 1 to 2 days later

    Contra-indications, adverse effects, precautions

    • Do not administer to patients with chronic adrenal failure or severe uncontrolled asthma.
    • May cause: gastrointestinal disturbances, vaginal bleeding, uterine contractions, headache.
    • Breast-feeding: no contra-indication for a single dose; to be avoided if multiple doses

    Remarks

    • Do not use mifepristone in ectopic or molar pregnancy.

    Storage

     
    –  
     
    – Below 25 °C